STOCKS TELEGRAPH

Tag: VEON stock

  • VEON Ltd. (VEON) surged in the current market; here is why?

    VEON Ltd. (VEON) surged in the current market; here is why?

    VEON Ltd. (VEON) gained in the current market after announcing the winning of the Global Mobile Award 2022. Its stock values are at $0.40, gaining more than 52.09% compared to yesterday’s closing price. The stock closed at $0.26 at the end of the last trading session. The stock volume traded in the previous trading session was around 17.85 million shares. The current market cap of the company is about $1.38 billion.

    VEON: Winner of Global Mobile Awards 2022

    The company has announced that its MobileID Service has won the Global Mobile Awards 2022 award for Best Mobile Operator Service for Connected Consumers. On March 2nd, 2022, at the Mobile World Congress in Barcelona in the Global Mobile Awards.

    The GSMA’s universal identity service, Mobile Connect, has constructed VEON’s MobileID. Customer authentication would not need any password. Using the Permission Centre module, users can manage and restrict rights previously granted to service providers, such as filling out credit application forms. A device’s SIM card is used to implement MobileID, allowing it to work on any handset, even feature phones.

    VEON CEO’s Remarks

    VEON CEO Kaan Terziolu expressed his joy at winning the Best Mobile Operator Service for Connected Consumers award. An industry-wide effort to ensure client data is protected and kept by licensed, regulated, and the Global Mobile Awards have recognized locally-based service providers. We will actively promote its use through operator acceptance and interoperability agreements.

    Conclusion

    The company is amongst Ukraine’s most extensive mobile networks. The current emergency in Ukraine has caused businesses to halt. The pandemic has already taken a toll on the company’s stock value. Despite reporting a strong financial statement for the fourth quarter of fiscal 2021, the stock has continued to drop. However, the company’s stock has risen in today’s trading session due to the company’s news that it had won the Global Mobile Awards 2022.

  • VEON Ltd. (VEON) stock gained in the Pre-market; here is why?

    VEON Ltd. (VEON) gained in the pre-market after announcing the resignation of Mr. Fridman, the director of BoD. VEON values at $0.42, gaining more than 10.53% compared to yesterday’s closing price. The stock closed at $0.38 at the end of the last trading session. The stock volume traded in the previous trading session was around 10.82 million shares. The current market cap of the company is about $1.11 billion.

    VEON: Resignation of the Director of Board of Director

    The company announced a recent change in the managerial position today. The company announced in a press release that Mr. Fridman has decided to resign from his position as a director of the VEON Board of Directors, effective February 28, 2022. The news is followed by the recent announcement of its fourth-quarter results, which was an incredible quarter.

    VEON: Q4 Key Highlights

    The company reported revenue of $2.05 billion compared to the revenue of $1.82 billion. The increase is around 11.1% YoY.

    The company reported a net income of $801 million in Q4 compared to the net loss of $315 million in the same period last year. The positive change in profitability in the trailing twelve months is phenomenal.

    The announcement recently showed its intention to shift its parent company group to the U.K. The company also announced its Russian Beeline mobile operator collaboration with Yandex.

    VTB Bank told the firm on February 17, 2022, that its subsidiary had entered into a seven-year RUB 30 billion (up to $400 million) loan with the bank. VEON Holdings B.V is guaranteeing the loan.

    Conclusion

    VEON Ltd. (VEON) is amongst Ukraine’s most extensive mobile networks. The current emergency in Ukraine has caused businesses to halt. VEON has been severely affected by the Russian invasion like other companies in Ukraine. Its stock was already down due to the hit by the pandemic. The current uncertain situation has escalated the decline in the stock, despite reporting a robust financial statement for the fourth quarter of fiscal 2021.

  • VEON Ltd. (VEON) Stock Dipped Today Despite Strong Financials

    VEON Ltd. (VEON) is an international-level provider of connectivity and digital services. The company’s goal is to empower client ambitions via technology, acting as a digital concierge to direct their choices and link them with resources that equate to their requirements.

    The price of VEON stock during the early trading on February 28, 2022, was last checked to be $0.63 with a decline of 21.6%.

    VEON: Events and Happenings

    On February 28, 2022, VEON updated the details related to its Group GEC pioneer incentive plan. On February 28, 2022, VEON reported its MobileID verification system had gained noteworthy user, operator, and digital business provision in its bid to become an international standard and swap verification via socializing networks.

    VEON: Key Financials

    On February 28, 2022, VEON released its financial statement for the fourth quarter ended 31 December 2021. Some of the notable points are discussed below.

    Revenue

    Revenue in Q4 2021 was $2.05 billion +11.1% YoY in local currency (+12.2% YoY reported currency) against $1.82 billion in the same quarter of 2020. The company observed a gain in its total revenue over the year.

    Net Income/Loss

    Net income in Q4 2021 was $801 million versus a net loss of $315 million in the same quarter of the previous year. The company observed a significant incline in its net income over the yearly period.

    On February 24, 2022, VEON announced its Always-on network service providing a facility that allowed online financial applications to continue even at the time of the suspension of mobile communication services. On February 17, 2022, the company was informed about the entry of its subsidiary into a RUB 30 billion (up to $400 million) seven-year period loan with VTB Bank. VEON Holdings B.V. is guaranteeing the loan.

    On February 3, 2022, VEON discussed its intention to move the parent company of its group to the UK. On December 27, 2021, the company reported its Russian Beeline mobile operator collaborated with Yandex. Plus to launch their initial joint tariff plan.

    Conclusion

    VEON stock down-performed by 63% from the past six months as the global economic condition is poor due to the pandemic. The company’s stock declined in the recent premarket despite it posting a strong quarterly result due to the ongoing Russia-Ukraine conflict. VEON is one of the biggest mobile operators in Ukraine.

  • Pre-Market Cues: 28 Stocks Roaring for Change On December 18th

    Pre-Market Cues: 28 Stocks Roaring for Change On December 18th

    Seneca Biopharma Inc. (SNCA), a Biotechnology company, rose about 0.2% at $0.96 in pre-market trading Friday after declaring merger agreement with Leading BioSciences, Inc. under which a wholly owned subsidiary of Seneca will merge with LBS in an all-stock transaction.

    Palantir Technologies Inc. (PLTR) lost over -3.97% at $26.15 in pre-market trading Friday December 18, 2020 after reporting that it will hold its inaugural “Live Demo Day” on Tuesday, January 26, 2021 at 4:30pm ET.

    Atossa Therapeutics Inc. (ATOS) stock plunged -0.02% to $0.86 in the pre-market trading following its declaration of pricing of $14.0 million registered direct offering priced at-the-market. The most recent rating by Maxim Group, on January 26, 2018, is a Buy.

    Virgin Galactic Holdings Inc. (NYSE: SPCE) shares are trading down -6.27% at $23.9 at the time of writing. The company recently revealed an update following its test flight on December 12, 2020. Company’s 52-week ranged between $9.06 to $42.49. Analysts have a consensus price target of $19.

    BlackBerry Limited (BB), a Software – Infrastructure company, dropped about -4.36% at $7.9 in pre-market trading Friday after releasing its financial results for the three months ended November 30, 2020

    Before the trading started on December 18, 2020, Uxin Limited (UXIN) is up 4.5% to reach $1.16 following its announcement of unaudited financial results for the quarter ended September 30, 2020. It has been trading in a 52-week range of $0.72 to $3.07.

    Coeur Mining Inc. (CDE) stock plunged -2.98% to $10.76 in the pre-market trading. The firm recently revealed details of the expansion of its Rochester silver-gold mine in Nevada, reflecting significant reserve growth and the benefits of a larger-scale expansion project. The most recent rating by Noble Capital Markets, on September 14, 2020, is an Outperform.

    Novan Inc. (NASDAQ: NOVN) shares are trading up 6.25% at $0.68 at the time of writing. The company lately reported that it has enrolled 525 patients of the approximately 850 patients expected to enroll in the B-SIMPLE4 pivotal Phase 3 clinical study of SB206. Company’s 52-week ranged between $0.22 to $3.72.

    CNS Pharmaceuticals Inc. (CNSP), a Biotechnology company, rose about 15.2% at $2.88 in pre-market trading Friday after announcing FDA approval of IND application for its brain cancer drug candidate Berubicin.

    United States Steel Corporation (X) stock moved down -4.26 percent to $17.77 in the pre-market trading after reporting that fourth quarter 2020 adjusted EBITDA is expected to be approximately $55 million and expected fourth quarter 2020 adjusted diluted loss per share to be approximately ($0.85).

    BioCardia Inc. (BCDA) lost over -6.09% at $4.01 in pre-market trading Friday December 18, 2020 following an announcement from the firm that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial.

    Before the trading started on December 18, 2020, Ampio Pharmaceuticals Inc. (AMPE) is up 8.43% to reach $1.93 after revealing the completion of its Phase I clinical trial and initiation of the first steps for a global Phase II clinical trial for intravenous (“IV”) Ampion treatment in COVID-19 patients. It has been trading in a 52-week range of $0.31 to $1.69.

    Drive Shack Inc. (NYSE: DS) shares are trading up 5.47% at $3.47 at the time of writing following the opening of its 65,000-square-foot entertainment golf venue located in Orlando. Company’s 52-week ranged between $0.86 to $4.19. Analysts have a consensus price target of $4.

    IZEA Worldwide Inc. (IZEA) tumbled over -3.7% at $1.04 in pre-market trading today. The company recently reported that it has just been awarded a mid-six figure contract from a Fortune 500 Manufacturer.

    Exela Technologies Inc. (XELA), a Software – Application company, rose about 81.87% at $0.66 in pre-market trading Friday after declaring that it has entered into a 5-year, $145 million term loan facility with Angelo Gordon, a global alternative investment firm.

    FedEx Corporation (FDX) stock moved down -2.89 percent to $283.8 in the pre-market trading after declaring strong results for the quarter ended November 30.

    Guardion Health Sciences Inc. (GHSI) stock plunged -2.13% to $0.23 in the pre-market trading. The firm recently declared progress on the introduction of its new vision support/energy drink, Epiq-V, which is under development for the United States and international markets.

    Amyris Inc. (NASDAQ: AMRS) shares are trading up 3.68% at $4.23 at the time of writing. Company’s 52-week ranged between $1.40 to $6.07. Analysts have a consensus price target of $3.35.

    Mereo BioPharma Group plc (MREO), a Biotechnology company, rose about 40.27% at $3.1 in pre-market trading Friday following the declaration of a license and collaboration agreement with Ultragenyx Pharmaceutical Inc. (RARE), for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta (OI).

    Surface Oncology Inc. (SURF) gained over 17.51% at $10.0 in pre-market trading Friday December 18, 2020 after revealing exclusive license agreement with GSK for novel immunotherapy program.

    Neovasc Inc. (NVCN) is down more than -8.52% at $0.91 in pre-market hours Friday December 18, 2020 after reporting the publication of peer-reviewed article in EuroIntervention. The stock had jumped over 3.61% to $0.99 in the last trading session.

    BioLineRx Ltd. (BLRX) tumbled over -1.1% at $2.7 in pre-market trading today. The firm lately declared final results from Phase 2a COMBAT/KEYNOTE-202 triple combination study of Motixafortide in second line Metastatic Pancreatic Cancer (PDAC).

    VYNE Therapeutics Inc. (VYNE), a Biotechnology company, rose about 8.05% at $1.88 in pre-market trading Friday after declaring the successful completion of its End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA).

    Before the trading started on December 18, 2020, Mesoblast Limited (MESO) is down -26.75% to reach $9.94 after announcing an update on COVID-19 ARDS trial. It has been trading in a 52-week range of $3.12 to $21.28.

    Applied DNA Sciences Inc. (APDN) stock plunged -12.02% to $5.49 in the pre-market trading after reporting consolidated financial results for the full fiscal year and quarter ended September 30, 2020. The most recent rating by H.C. Wainwright, on July 20, 2020, is a Buy.

    Conformis Inc. (NASDAQ: CFMS) shares are trading up 3.8% at $0.6693 at the time of writing. The firm lately revealed the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. Company’s 52-week ranged between $0.50 to $1.66.

    Auris Medical Holding Ltd. (EARS) grew over 1.5% at $2.7 in pre-market trading today. The company recently provided a business update related to the Company’s funding position, its AM-301 program for the protection against airborne pathogens and allergens and the ongoing strategy review process.

    Sonoma Pharmaceuticals Inc. (SNOA) stock moved up 19.79 percent to $9.14 in the pre-market trading following the announcement of partnership with Gabriel Science, LLC for dental.